cSMART 2.0 (Supplementary Fig. 1) was used to detect rare variants in the UTR region of CD274 gene in multi-omics methodology for the first time in a large-scale retrospective cohort covered a variety of tumor types, while correlating their presence with the efficacy of immunotherapy. The gene discussed is CD274; the disease is neoplasm.